Non-immune hydrops fetalis: changing contribution to perinatal mortality
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1983.tb09281.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b)
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 90, Issue 7, pages 636–639, July 1983
Additional Information
How to Cite
ANDERSEN, H. M., DREW, J. H., BEISCHER, N. A., HUTCHISON, A. A. and FORTUNE, D. W. (1983), Non-immune hydrops fetalis: changing contribution to perinatal mortality. BJOG: An International Journal of Obstetrics & Gynaecology, 90: 636–639. doi: 10.1111/j.1471-0528.1983.tb09281.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Received J September 1982 Accepted 15 March 1983
- Abstract
- References
- Cited By
Summary. During the decade to 1979, 203 hydropic infants died in the State of Victoria, Australia. Non-immune hydrops fetalis (NIHF) became more common than immune hydrops fetalis as a cause of fetal hydrops, and its contribution to the total perinatal mortality increased from 0.1% to 3%. The perinatal mortality rate of infants with NIHF was virtually 100%. The most consistent finding at post-mortem was pulmonary hypoplasia which was probably due to compression from serous cavity effusions. Survival may be improved by early diagnosis and termination of the pregnancy in selected patients with viable infants before the development of gross serous cavity effusions The most constant clinical sign associated with hydrops fetalis was polyhydramnios which is an indication for ultrasonography and cardiotocography to detect cases of NIHF and to select the optimum time for delivery.

1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)